Next Article in Journal
Introduction to Special Issue on “Electromagnetic Technologies for Medical Diagnostics: Fundamental Issues, Clinical Applications and Perspectives”
Next Article in Special Issue
Roles of ERCP in the Early Diagnosis of Pancreatic Cancer
Previous Article in Journal
Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
Previous Article in Special Issue
Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer
Open AccessReview

Advances in Early Detection of Pancreatic Cancer

1
Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan
2
Japan Study Group on the Early Detection of Pancreatic Cancer (JEDPAC), Onomichi 722-8508, Japan
3
Department of Gastroenterology, JA Onomichi General Hospital, Onomichi 722-8508, Japan
4
Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Komagome Hospital, Tokyo 113-0021, Japan
5
Department of Gastroenterology, Wakayama Medical University School of Medicine, Wakayama 641-0012, Japan
*
Author to whom correspondence should be addressed.
Diagnostics 2019, 9(1), 18; https://doi.org/10.3390/diagnostics9010018
Received: 10 January 2019 / Revised: 24 January 2019 / Accepted: 28 January 2019 / Published: 5 February 2019
(This article belongs to the Special Issue Early Diagnosis of Pancreatic Cancer)
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. PDAC is the fourth leading cause of death in the United States and Japan based on epidemiological data. Early detection of PDAC is very important to improve the prognosis of PDAC. Early detection of pancreatic ductal adenocarcinoma (PDAC) requires further examination after selecting cases with risk factors for the condition, such as family history, hereditary pancreatic carcinoma syndrome, intraductal papillary mucinous neoplasms, or chronic pancreatitis. The Japan Study Group on the Early Detection of Pancreatic Cancer has investigated and clarified the clinicopathological features for the early diagnosis of PDAC. In Japan, an algorithm for the early diagnosis of PDAC, which utilized the cooperation of local clinics and regional general hospitals, has been a breakthrough in the detection of early-stage PDAC. Further approaches for the early diagnosis of PDAC are warranted. View Full-Text
Keywords: pancreatic ductal cell carcinoma; PDAC; early stage; ERCP pancreatic ductal cell carcinoma; PDAC; early stage; ERCP
Show Figures

Graphical abstract

MDPI and ACS Style

Kanno, A.; Masamune, A.; Hanada, K.; Kikuyama, M.; Kitano, M. Advances in Early Detection of Pancreatic Cancer. Diagnostics 2019, 9, 18.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop